# An Independent Reading Room, Not a Store > About Formula1 Peptides — Recovery & Tissue Repair Research — Formula1 Peptides is an independent literature digest on tissue-repair research peptides — not a clinic, not a supplier, not medical advice. **ABOUT** Why Formula1 Peptides exists, how it reads the literature, and what it will never claim. ## What this site is Formula1 Peptides is an independent literature review covering three peptides studied for tissue repair — BPC-157, TB-500, and the four-peptide blend KLOW. It is not a clinic, not a supplier, and not a research chemical vendor. Nothing on this site is for sale, and nothing here is medical advice or a recommendation to use any of the compounds it describes. ## The frame: high-performance repair The organizing question across this site is return-to-play and load tolerance — how fast tissue rebuilds after injury and how much stress it can safely bear again during that process. That lens is not a claim about approved or safe use for athletes; it is an editorial choice about which findings in the underlying literature get emphasized. Two of the three compounds covered here are explicitly prohibited in competitive sport, and none is approved for any human use. ## How to read this site Every content page separates three kinds of information clearly: cited findings from peer-reviewed and pre-print studies, labeled community reports (marked anecdotal, not clinical evidence, and never carrying a dose), and cited safety cautions grounded in mechanism or the published literature. Bracketed numbers like [1] link to the full [references](/references) list at the foot of the site. Where evidence is thin — which is often, for compounds this early in the research pipeline — the text says so rather than smoothing it over. ## Editorial stance None of the three compounds covered here is FDA-approved for human use. BPC-157 and TB-500 are prohibited in competitive sport by the World Anti-Doping Agency; using either — or KLOW, which contains TB-500 — implicates anti-doping rules for tested athletes regardless of intent. This site never recommends a dose, never frames any compound as validated for human use, and reports doses only exactly as a cited study used them, never as a suggestion. Where the underlying research disagrees with common marketing claims — such as extrapolating full-length thymosin beta-4 data onto the TB-500 fragment, or presenting KLOW's four-peptide combination as tested when it is not — this site says so directly. ## What this site will not do This site will not list a personal dose, will not describe a course of administration, and will not frame community anecdotes as clinical proof. Every reported effect drawn from peptide-user forums or wellness-clinic write-ups is labeled anecdotal, not clinical evidence, and is kept separate from the peer-reviewed findings it sits alongside. Where a compound's evidence rests on a different molecule than the one actually sold — as with TB-500 and full-length thymosin beta-4 — the distinction is stated plainly rather than glossed over, because collapsing that distinction is one of the most common ways this category of research gets overstated online. ## Why the compound selection BPC-157, TB-500, and KLOW were grouped together because they share a research theme — tissue repair, connective-tissue healing, and recovery — even though their individual evidence bases differ sharply in size and quality. Reading them side by side, rather than in isolation, is the point of a themed hub like this one: it makes the differences in evidence maturity, mechanism, and regulatory standing visible in a way that a single product page never would. The [comparison page](/compare) is built for exactly that kind of side-by-side reading. --- Formula1 Peptides is an independent tissue-repair literature review, not a clinic, not a formulator, and not a substitute for reading the cited studies yourself.